Citigroup Maintains Buy on Amrize, Lowers Price Target to $58
Citigroup analyst Anthony Pettinari maintains Amrize (NYSE: AMRZ ) with a Buy and lowers the price target from $66 to $58.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.